The host immune response of BM NK cells against MM is inhibited via the following events: decreased ADCC, especially in advanced disease, decreased NKG2D, 2B4, and DNAM-1 (without changes in NCR) expression, and de novo programmed cell death receptor (PD-1) expression [57]. Here, KLRK1 is linked to Miyoshi myopathy.